The DOI matches its Crossref record; 37 of the 38 references it cites were found in a registry or an index.
The Role of α6-Containing Nicotinic Acetylcholine Receptors in Nicotine Reward and Withdrawal
Open accessAbstract
The alpha6 nicotinic acetylcholine receptor (nAChR) subunit is involved in nicotine-stimulated dopamine release in the striatum. It is expressed in brain regions and coexpressed with nAChR subtypes implicated in nicotine dependence behaviors; hence, this subunit may play a role in nicotine dependence. Using the alpha6-selective antagonist alpha-conotoxin H9A;L15A (MII[H9A;L15A]), we determined the role of alpha6* nAChRs in the pharmacological and behavioral effects of nicotine. We measured effects of pretreatment with MII[H9A;L15A] on analgesia, locomotion, and body temperature after a single injection of nicotine. Effects of MII[H9A;L15A] on nicotine reward were measured using the conditioned place preference (CPP) paradigm. We further measured physical (somatic signs and hyperalgesia) and affective [anxiety-related behavior and conditioned place aversion (CPA)] nicotine withdrawal behaviors after extended nicotine exposure. Results showed that MII[H9A;L15A] did not block acute nicotine effects on the behaviors measured. Conversely, MII[H9A:l15A] blocked the expression of nicotine CPP, as well as withdrawal-associated CPA and anxiety-related behavior in the elevated plus maze, but not withdrawal-induced somatic signs or hyperalgesia. These results suggest a role for the alpha6 nAChR subunit in nicotine reward and affective nicotine withdrawal but not acute nicotine-induced or physical withdrawal behaviors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“There was no influence on the somatic symptoms of withdrawal, suggesting a selective role for α6 nAChR subunits in the affective manifestations of withdrawal (Jackson et al. 2009).”
From Nicotine Withdrawal (2015) · cites this paper as Jackson et al. 2009
The cited source says what the claim attributes to it.
In the citing paper
“and there is a documented role for α6* nAChRs in withdrawal-induced CPA (Jackson et al. 2009).”
From Nicotine Withdrawal (2015) · cites this paper as Jackson et al. 2009
In the citing paper
“Pharmacological studies in nAChR null mice indicate that β2-containing and α6-containing nAChRs are necessary for CPA, but neither the α5, nor the α7 subunits affect CPA behavior [170, 172, 189].”
From Mechanistic insights into nicotine withdrawal (2011) · cites this paper as [172]
In the citing paper
“Interestingly, somatic signs of withdrawal are preserved in mice lacking the β2 or the α6 nAChR subunits [11, 172]”
From Mechanistic insights into nicotine withdrawal (2011) · cites this paper as [172]
In the citing paper
“So far, it has been established that the β2 and α6 nAChR subunits are necessary for increased anxiety during withdrawal [170, 172], whereas, α5 and α7 may not be required [170].”
From Mechanistic insights into nicotine withdrawal (2011) · cites this paper as [172]
In the citing paper
“In addition, infusion and systemic administration of drugs that selectively inhibit ␣42* and/or ␣62* nAChRs blocked behaviors linked to nicotine reward and reinforcement”
From Varenicline Is a Potent Partial Agonist at α6β2* Nicotinic Acetylcholine Receptors in Rat and Monkey Striatum (2012) · cites this paper as Jackson et al., 2009
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Picciotto, M. R., Zoli, M., Rimondini, R., Léna, C., Marubio, L. M., Pich, E. M., Fuxe, K., & Changeux, J.-P. (1998) · Nature · doi:10.1038/34413 · Cited by 1,320
Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs.
Pontieri, F. E., Tanda, G., Orzi, F., & Chiara, G. D. (1996) · Nature · doi:10.1038/382255a0 · Cited by 1,073
The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine
Corrigall, W. A., Franklin, K. B. J., Coen, K. M., & Clarke, P. B. S. (1992) · Psychopharmacology · doi:10.1007/bf02245149 · Cited by 829
Corrigall, W. A., Coen, K. M., & Adamson, K. L. (1994) · Brain Research · doi:10.1016/0006-8993(94)90401-4 · Cited by 740
Nicotine Activation of α4* Receptors: Sufficient for Reward, Tolerance, and Sensitization
Tapper, A. R., McKinney, S. L., Nashmi, R., Schwarz, J., Deshpande, P., Labarca, C., Whiteaker, P., Marks, M. J., Collins, A. C., & Lester, H. A. (2004) · Science · doi:10.1126/science.1099420 · Cited by 686
Klink, R., d'Exaerde, A. D. K., Zoli, M., & Changeux, J.-P. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-05-01452.2001 · Cited by 674
Molecular and cellular aspects of nicotine abuse
Dani, J. A., & Heinemann, S. (1996) · Neuron · doi:10.1016/s0896-6273(00)80112-9 · Cited by 605
Reduced antinociception in mice lacking neuronal nicotinic receptor subunits
Marubio, L. M., Jiménez, M. D. M. A., Cordero‐Erausquin, M., Léna, C., Novère, N. G. L., d’Exaerde, A. D. K., Huchet, M., Damaj, M. I., & Changeux, J. (1999) · Nature · doi:10.1038/19756 · Cited by 538
Self-citationChamptiaux, N., Gotti, C., Cordero‐Erausquin, M., David, D. J. P., Przybylski, C., Léna, C., Clementi, F., Moretti, M., Rossi, F., Novère, N. G. L., et al. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-21-07820.2003 · Cited by 512
Self-citationBenwell, M. E. M., & Balfour, D. J. K. (1992) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1992.tb09067.x · Cited by 426
Cited by
Sorted by citations
Nicotine addiction and nicotinic receptors: lessons from genetically modified mice
Changeux, J.-P. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2849 · Cited by 453
Nicotinic acetylcholine receptors and nicotine addiction: A brief introduction
Wittenberg, R. E., Wolfman, S. L., Biasi, M. D., & Dani, J. A. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108256 · Cited by 221
McLaughlin, I., Dani, J. A., & De Biasi, M. (2015) · Current Topics in Behavioral Neurosciences · doi:10.1007/978-3-319-13482-6_4 · Cited by 191
The habenulo-interpeduncular pathway in nicotine aversion and withdrawal
Antolin-Fontes, B., Ables, J. L., Görlich, A., & Ibañez-Tallon, I. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.11.019 · Cited by 154
Berrendero, F., Robledo, P., Trigo, J. M., Martín-García, E., & Maldonado, R. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.02.006 · Cited by 140
Nicotinic acetylcholine receptors: Conventional and unconventional ligands and signaling
Papke, R. L., & Lindstrom, J. M. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108021 · Cited by 128
Pain, nicotine, and tobacco smoking: current state of the science
LaRowe, L. R., & Ditre, J. W. (2020) · Pain · doi:10.1097/j.pain.0000000000001874 · Cited by 122
Neurobiological Mechanisms of Nicotine Reward and Aversion
Wills, L. P., Ables, J. L., Braunscheidel, K. M., Caligiuri, S. P. B., Elayouby, K. S., Fillinger, C., Ishikawa, M., Moen, J. K., & Kenny, P. J. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.121.000299 · Cited by 134
New mechanisms and perspectives in nicotine withdrawal
Jackson, K. J., Muldoon, P. P., Biasi, M. D., & Damaj, M. I. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.11.009 · Cited by 109
Self-citationThe role of the habenula in the transition from reward to misery in substance use and mood disorders
Batalla, A., Homberg, J. R., Lipina, T. V., Sescousse, G., Luijten, M., Ivanova, S. А., Schellekens, A., & LOONEN, A. J. M. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.03.019 · Cited by 101
Negative affective states and cognitive impairments in nicotine dependence
Hall, F. S., Der‐Avakian, A., Gould, T. J., Markou, A., Shoaib, M. C., & Young, J. W. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.06.004 · Cited by 110
Inside-out neuropharmacology of nicotinic drugs
Henderson, B. J., & Lester, H. A. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.01.022 · Cited by 109
Kuryatov, A., & Lindstrom, J. M. (2010) · Molecular Pharmacology · doi:10.1124/mol.110.066159 · Cited by 97
Quik, M., Perez, X. A., & Grady, S. R. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.06.001 · Cited by 97
Anxiety and Depression in Bidirectional Relations Between Pain and Smoking
Zale, E. L., Maisto, S. A., & Ditre, J. W. (2015) · Behavior Modification · doi:10.1177/0145445515610744 · Cited by 93
Pang, X.-Y., Liu, L., Ngolab, J., Zhao-Shea, R., McIntosh, J. M., Gardner, P. D., & Tapper, A. R. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.03.039 · Cited by 89
Self-citationTurner, J. R., Castellano, L. M., & Blendy, J. A. (2011) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntq206 · Cited by 78
Nicotine exploits a COPI-mediated process for chaperone-mediated up-regulation of its receptors
Henderson, B. J., Srinivasan, R., Nichols, W. A., Dilworth, C. N., Gutierrez, D. F., Mackey, E. D. W., McKinney, S., Drenan, R. M., Richards, C. I., & Lester, H. A. (2014) · Journal of General Physiology · doi:10.1085/jgp.201311102 · Cited by 78
Azam, L., Maskos, U., Changeux, J., Dowell, C. D., Christensen, S. B., Biasi, M. D., & McIntosh, J. M. (2010) · The FASEB Journal · doi:10.1096/fj.10-166272 · Cited by 77
Self-citationToll, L., Zaveri, N. T., Polgar, W. E., Jiang, F., Khroyan, T. V., Zhou, W., Xie, X., Stauber, G. B., Costello, M. R., & Leslie, F. M. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.322 · Cited by 80
Nicotinic acetylcholine receptors in dorsal root ganglion neurons include the α6β4 subtype
Hone, A. J., Meyer, E. L., McIntyre, M., & McIntosh, J. M. (2011) · The FASEB Journal · doi:10.1096/fj.11-195883 · Cited by 76
Self-citationUnderstanding the habenula: A major node in circuits regulating emotion and motivation
Ables, J. L., Park, K., & Ibáñez-Tallon, I. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106734 · Cited by 79
The Molecular Neurobiology of Twelve Steps Program & Fellowship: Connecting the Dots for Recovery
Blum, K., Thompson, B., Demotrovics, Z., Femino, J., Giordano, J., Oscar-Berman, M., Teitelbaum, S., Smith, D. E., Roy, A. K., Agan, G., et al. (2015) · Journal of Reward Deficiency Syndrome · doi:10.17756/jrds.2015-008 · Cited by 73
Cohen, A., Treweek, J. B., Edwards, S., Leão, R. M., Schulteis, G., Koob, G. F., & George, O. (2013) · Addiction Biology · doi:10.1111/adb.12077 · Cited by 73
Ditre, J. W., Zale, E. L., LaRowe, L. R., Kosiba, J. D., & Vita, M. J. D. (2018) · Journal of Abnormal Psychology · doi:10.1037/abn0000353 · Cited by 73
Sanjakdar, S. S., Maldoon, P. P., Marks, M. J., Brunzell, D. H., Maskos, U., McIntosh, J. M., Bowers, M. S., & Damaj, M. I. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.177 · Cited by 74
Self-citationBordia, T., Hrachova, M., Chin, M., McIntosh, J. M., & Quik, M. (2012) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.194852 · Cited by 70
Self-citationJackson, K. J., Sanjakdar, S. S., Muldoon, P. P., McIntosh, J. M., & Damaj, M. I. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.01.017 · Cited by 69
Self-citationCohen, A., & George, O. (2013) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2013.00041 · Cited by 70
Mechanistic insights into nicotine withdrawal
Paolini, M., & De Biasi, M. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.07.075 · Cited by 66
Luo, S., Zhangsun, D., Wu, Y., Zhu, X., Hu, Y., McIntyre, M., Christensen, S. B., Akcan, M., Craik, D. J., & McIntosh, J. M. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.427898 · Cited by 62
Self-citationAddiction‐related neuroadaptations following chronic nicotine exposure
Wills, L., & Kenny, P. J. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15356 · Cited by 61
Nicotinic Receptor Contributions to Smoking: Insights from Human Studies and Animal Models
Brunzell, D. H., Stafford, A. M., & Dixon, C. I. (2015) · Current Addiction Reports · doi:10.1007/s40429-015-0042-2 · Cited by 58
Self-citationNicotinic Receptor Antagonists as Treatments for Nicotine Abuse
Crooks, P. A., Bardo, M. T., & Dwoskin, L. P. (2014) · Advances in pharmacology · doi:10.1016/b978-0-12-420118-7.00013-5 · Cited by 57
Hone, A. J., Ruiz, M., Scadden, M., Christensen, S. B., Gajewiak, J., Azam, L., & McIntosh, J. M. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.482059 · Cited by 52
Self-citationAssessing nicotine dependence using an oral nicotine free-choice paradigm in mice
Bağdaş, D., Diester, C. M., Riley, J., Carper, M., Alkhlaif, Y., Alomari, D., Alayoubi, H., Poklis, J. L., & Damaj, M. I. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.107669 · Cited by 55
Self-citationDrenan, R. M., & Lester, H. A. (2012) · Pharmacological Reviews · doi:10.1124/pr.111.004671 · Cited by 55
Drug withdrawal-induced depression: Serotonergic and plasticity changes in animal models
Renoir, T., Pang, T. Y., & Lanfumey, L. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2011.10.003 · Cited by 56
Powers, M. S., Broderick, H. J., Drenan, R. M., & Chester, J. A. (2013) · Genes Brain & Behavior · doi:10.1111/gbb.12042 · Cited by 49
Hone, A. J., Scadden, M., Gajewiak, J., Christensen, S. B., Lindstrom, J. M., & McIntosh, J. M. (2012) · Molecular Pharmacology · doi:10.1124/mol.112.080853 · Cited by 46
Self-citationLong-Term Nicotine Exposure Depresses Dopamine Release in Nonhuman Primate Nucleus Accumbens
Perez, X. A., Ly, J., McIntosh, J. M., & Quik, M. (2012) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.194084 · Cited by 44
Self-citationSchilaty, N. D., Hedges, D. M., Jang, E. Y., Folsom, R. J., Yorgason, J. T., McIntosh, J. M., & Steffensen, S. C. (2014) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.211490 · Cited by 47
Self-citationBrunzell, D. H., McIntosh, J. M., & Papke, R. L. (2014) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12421 · Cited by 43
Self-citationMidde, N. M., Gomez, A. M., Harrod, S. B., & Zhu, J. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.03.013 · Cited by 39
Anderson, S. M., & Brunzell, D. H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048665 · Cited by 41
Self-citationPharmacogenetics of smoking cessation: role of nicotine target and metabolism genes
Gold, A. B., & Lerman, C. E. (2012) · Human Genetics · doi:10.1007/s00439-012-1143-9 · Cited by 41
Progress and challenges in the study of α6-containing nicotinic acetylcholine receptors
Letchworth, S. R., & Whiteaker, P. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.06.022 · Cited by 40
The effects of lobeline on nicotine withdrawal-induced depression-like behavior in mice
Roni, M. A., & Rahman, S. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3472-y · Cited by 39
Xiao, C., Srinivasan, R., Drenan, R. M., Mackey, E. D. W., McIntosh, J. M., & Lester, H. A. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.05.005 · Cited by 37
Self-citationCahir, E., Pillidge, K., Drago, J., & Lawrence, A. J. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.35 · Cited by 37
Unraveling the neurobiology of nicotine dependence using genetically engineered mice
Stoker, A. K., & Markou, A. (2013) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2013.02.013 · Cited by 38
Nicotine regulates activity of lateral habenula neurons via presynaptic and postsynaptic mechanisms
Zuo, W., Xiao, C., Gao, M., Hopf, F. W., Krnjević, K., McIntosh, J. M., Fu, R., Wu, J., Bekker, A., & Ye, J.-H. (2016) · Scientific Reports · doi:10.1038/srep32937 · Cited by 33
Self-citationAssessment of nicotine withdrawal-induced changes in sucrose preference in mice
Alkhlaif, Y., Bağdaş, D., Jackson, A. B., Park, A. J., & Damaj, M. I. (2017) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2017.08.013 · Cited by 33
Self-citationSajja, R. K., & Rahman, S. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2012.03.017 · Cited by 33
Brunzell, D. H. (2012) · Nicotine & Tobacco Research · doi:10.1093/ntr/nts089 · Cited by 36
Self-citationDivergent Functional Effects of Sazetidine-A and Varenicline During Nicotine Withdrawal
Turner, J. R., Wilkinson, D. S., Poole, R. L., Gould, T. J., Carlson, G. C., & Blendy, J. A. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.105 · Cited by 29
Perez, X. A., Khroyan, T. V., McIntosh, J. M., & Quik, M. (2014) · Pharmacology Research & Perspectives · doi:10.1002/prp2.105 · Cited by 30
Self-citationCholinergic Receptors and Addiction
Papke, R. L., Brunzell, D. H., & Biasi, M. D. (2020) · Current topics in behavioral neurosciences · doi:10.1007/7854_2020_139 · Cited by 30
Self-citationAlpha6-containing nicotinic acetylcholine receptor is a highly sensitive target of alcohol
Gao, F., Chen, D., Ma, X., Sudweeks, S. N., Yorgason, J. T., Gao, M., Turner, D., Eaton, J. B., McIntosh, J. M., Lukas, R. J., et al. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.01.021 · Cited by 34
Self-citationNative α6β4∗ nicotinic receptors control exocytosis in human chromaffin cells of the adrenal gland
Pérez‐Alvarez, A., Hernández‐Vivanco, A., McIntosh, J. M., & Albillos, A. (2011) · The FASEB Journal · doi:10.1096/fj.11-190223 · Cited by 29
Self-citationAttenuation by baclofen of nicotine rewarding properties and nicotine withdrawal manifestations
Varani, A. P., Aso, E., Moutinho, L. M., Maldonado, R. J., & Balerio, G. N. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3469-6 · Cited by 28
α6 nAChR subunit residues that confer α‐conotoxin BuIA selectivity
Kim, H., & McIntosh, J. M. (2012) · The FASEB Journal · doi:10.1096/fj.12-204487 · Cited by 27
Self-citationLiu, W., & Li, M. D. (2017) · Current Neuropharmacology · doi:10.2174/1570159x15666170801103009 · Cited by 28
Tae, H., & Adams, D. J. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106747 · Cited by 27
Lotfipour, S., Mandelkern, M. A., Alvarez-Estrada, M., & Brody, A. L. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.20 · Cited by 26
Perez, X. A., McIntosh, J. M., & Quik, M. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12442 · Cited by 28
Self-citationWen, L., Yang, Z., Cui, W., & Li, M. D. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.103 · Cited by 27
Endogenous opioid system: a promising target for future smoking cessation medications
Norman, H., & D’Souza, M. S. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4582-0 · Cited by 23
You, S., Li, X., Xiong, J., Zhu, X., Zhangsun, D., Zhu, X., & Luo, S. (2019) · Marine Drugs · doi:10.3390/md17090490 · Cited by 22
Effects of nicotine deprivation on current pain intensity among daily cigarette smokers.
LaRowe, L. R., Kosiba, J. D., Zale, E. L., & Ditre, J. W. (2018) · Experimental and Clinical Psychopharmacology · doi:10.1037/pha0000218 · Cited by 21
Kamens, H. M., Miyamoto, J. H., Powers, M. S., Ro, K., Soto, M., Cox, R. J., Stitzel, J. A., & Ehringer, M. A. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.08.035 · Cited by 21
Expression of cloned α6* nicotinic acetylcholine receptors
Wang, J., Kuryatov, A., & Lindstrom, J. M. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.10.009 · Cited by 21
Hall, F. S., Markou, A., Levin, E. D., & Uhl, G. R. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06415.x · Cited by 18
Steffensen, S. C., Shin, S. I., Nelson, A. C., Pistorius, S. S., Williams, S. B., Woodward, T. J., Park, H.-J., Friend, L. N., Gao, M., Gao, F., et al. (2017) · Addiction Biology · doi:10.1111/adb.12559 · Cited by 18
Self-citationVarani, A. P., Pedrón, V. T., Moutinho, L. M., Antonelli, M. C., Bettler, B., & Balerio, G. N. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.11.013 · Cited by 17
Biała, G., Polak, P., Michalak, A., Kruk-Słomka, M., & Budzyńska, B. (2014) · Pharmacological Reports · doi:10.1016/j.pharep.2014.02.003 · Cited by 17
Zhu, J., Midde, N. M., Gomez, A. M., Sun, W., & Harrod, S. B. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00540 · Cited by 16
Corrie, L. W.-C., Stokes, C. A., Wilkerson, J. L., Carroll, F. I., McMahon, L. R., & Papke, R. L. (2020) · Molecular Pharmacology · doi:10.1124/molpharm.120.000037 · Cited by 19
Freitas, K., Carroll, F. I., & Negus, S. S. (2015) · Experimental and Clinical Psychopharmacology · doi:10.1037/pha0000055 · Cited by 16
Chen, J., Brunzell, D. H., Jackson, K. J., van der Vaart, A. D., Ma, J. Z., Payne, T. J., Sherva, R., Farrer, L. A., Gejman, P. V., Levinson, D. F., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028790 · Cited by 15
Self-citationJackson, K. J., & Damaj, M. I. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.12.005 · Cited by 16
Self-citationMolecular, Neuronal, and Behavioral Effects of Ethanol and Nicotine Interactions
Klenowski, P. M., & Tapper, A. R. (2018) · Handbook of experimental pharmacology · doi:10.1007/164_2017_89 · Cited by 15
Genetic matters: Thirty years of progress using mouse models in nicotinic research
Marks, M. J. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.05.021 · Cited by 13
A role for α4(non-α6)* nicotinic acetylcholine receptors in motor behavior
Soll, L. G., Grady, S. R., Salminen, O., Marks, M. J., & Tapper, A. R. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.05.001 · Cited by 15
Guildford, M. J., Sacino, A. V., & Tapper, A. R. (2016) · Alcohol · doi:10.1016/j.alcohol.2016.08.006 · Cited by 14
Li, W., Han, H., Liu, Q., Su, K., Yang, Z., Cui, W., Yuan, W., Ma, Y., Fan, R., Chen, J., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-09492-8 · Cited by 15
Nega, S., Marquez, P. V., Hamid, A., Ahmad, S. M., & Lutfy, K. (2020) · Journal of Neuroscience Research · doi:10.1002/jnr.24649 · Cited by 14
Brain Nicotinic Receptors as Emerging Targets for Drug Addiction
Rahman, S. (2011) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-385506-0.00008-9 · Cited by 14
Neuroscience of nicotine for addiction medicine
D’Souza, M. S. (2015) · Progress in brain research · doi:10.1016/bs.pbr.2015.07.008 · Cited by 13
Deletion of lynx1 reduces the function of α6* nicotinic receptors
Parker, R. L., O’Neill, H. C., Henley, B. M., Wageman, C. R., Drenan, R. M., Marks, M. J., Miwa, J. M., Grady, S. R., & Lester, H. A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0188715 · Cited by 14
Lee, B. G., Anastasía, A., Hempstead, B. L., Lee, F. S., & Blendy, J. A. (2015) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntv047 · Cited by 13
Li, X., You, S., Xiong, J., Qiao, Y., Yu, J., Zhangsun, D., & Luo, S. (2020) · Marine Drugs · doi:10.3390/md18120646 · Cited by 12
Monkey Adrenal Chromaffin Cells Express α6β4* Nicotinic Acetylcholine Receptors
Hernández‐Vivanco, A., Hone, A. J., Scadden, M., Carmona‐Hidalgo, B., McIntosh, J. M., & Albillos, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094142 · Cited by 12
Self-citationCardenas, A. M., Bai, Y., Heydary, Y. H., Li, J., Leslie, F. M., & Lotfipour, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063145 · Cited by 12
Collo, G., Cavalleri, L., Zoli, M., Maskos, U., Ratti, E., & Pich, E. M. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00572 · Cited by 10
More than Smoke and Patches: The Quest for Pharmacotherapies to Treat Tobacco Use Disorder
Moerke, M. J., McMahon, L. R., & Wilkerson, J. L. (2020) · Pharmacological Reviews · doi:10.1124/pr.119.018028 · Cited by 11
Carroll, F. I., Navarro, H. A., Mascarella, S. W., Castro, A. H., Luetje, C. W., Wageman, C. R., Marks, M. J., Jackson, A. B., & Damaj, M. I. (2015) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5b00077 · Cited by 10
Self-citationConditioned Place Preference as a Preclinical Model for Screening Pharmacotherapies for Drug Abuse
Bardo, M. T., Horton, D. B., & Yates, J. R. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-420172-9.00007-2 · Cited by 9
Bağdaş, D., AlSharari, S. D., Roni, M. A., Campbell, V. C., Muldoon, P. P., Carroll, F. I., & Damaj, M. I. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2018.12.027 · Cited by 9
Self-citationTC299423, a Novel Agonist for Nicotinic Acetylcholine Receptors
Wall, T. R., Henderson, B. J., Voren, G., Wageman, C. R., Deshpande, P., Cohen, B. N., Grady, S. R., Marks, M. J., Yohannes, D., Kenny, P. J., et al. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00641 · Cited by 8
Metadata
- Authors
- Jackson, K. J., McIntosh, J. M., Brunzell, D. H., Sanjakdar, S. S., & Damaj, M. I.
- Affiliations
- Virginia Commonwealth University (US)
- Venue
- The Journal of Pharmacology and Experimental Therapeutics
- Publisher
- Elsevier BV
- Published
- 2009-11
- Volume
- 331
- Issue
- 2
- Pages
- 547-554
- ISSN
- 0022-3565 (ISSN-L)
- PMC
- PMC2775251
- OpenAlex
- W2133971381
- Cited by
- 135
- References
- 38
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 3 · 2023: 8 · 2022: 3 · 2021: 2 · 2020: 8 · 2019: 7 · 2018: 6 · 2017: 8 · 2016: 8 · 2015: 15 · 2014: 17 · 2013: 13 · 2012: 14
- FWCI
- 4.29
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Pharmacology and Experimental Therapeutics (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (MH53631, GM 48677)
- National Institute of Mental Health (MH53631, R01MH053631, R29MH053631)
- National Institute on Drug Abuse (R01DA012610, DA 05274, DA-12610, R03DA023114, DA023114, P50DA005274)
- National Institute of General Medical Sciences (P01GM048677, GM48677)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- nicotine reward, nicotine withdrawal, conditioned place preference, conditioned place aversion, anxiety-like behavior, nicotine dependence, dopamine release, striatum, hyperalgesia, locomotion, analgesia, body temperature
- MeSH terms
- Animals, Anxiety, Avoidance Learning, Body Temperature, Calcium Channel Blockers, Conditioning, Operant, Dose-Response Relationship, Drug, Injections, Intraventricular, Male, Mice, Inbred C57BL, Motor Activity, Nicotine, Pain Measurement, Reaction Time, Receptors, Nicotinic, Reward, Substance Withdrawal Syndrome, Nicotinic Agonists, Nicotinic Antagonists, Conotoxins, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review